d.s.h. statistical services GmbH   Report issue

For profit Phase 2 Phase 4
Founded: Rohrbach Germany (1987)

Organization Overview

First Clinical Trial
2012
NCT01757613
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

d.s.h. statistical services GmbH

Active Ingredients

Drugs in Phase 4 Trials (1)

echinacea (1 trial)

Drugs in Phase 2 Trials (1)

ak 3012 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2